Patent Assignment
Reel/Frame 035486/0554
Security Interest
Recorded: 2015-04-23
Pages: 21
Assignor
INTERHEALTH NUTRACEUTICALS INCORPORATED
Executed: 2014-08-18
Assignee
MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
30 S. WACKER DRIVE, SUITE 3700, CHICAGO, ILLINOIS, 60606
Covered Properties
(34)
Treatment Process for Promoting Weight Loss Employing a Substituted DELTA5-Androstene
Application:
07/575,156 →
Treatment Process for Promoting Weight Loss Employing a Substituted DELTA5-Androstene
Patent:
5,296,481 →
Application:
07/867,288 →
Modulation of Immune System with Delta 5 -Androstenes
Patent:
5,292,730 →
Application:
07/922,850 →
Treatment of Immune System with Delta 5-Androstenes
Patent:
5,585,371 →
Application:
08/189,917 →
Up-Regulation of Immune System with Delta 5-Androstenes
Patent:
5,641,766 →
Application:
08/527,746 →
Use of DELTA5 Androstenes in the Treatment of Hiv Wasting Syndrome
Patent:
5,885,977 →
Application:
08/784,856 →
Treatment of Alzheimer's Disease and Modulation of Immune System with Delta 5-Androstenes
Patent:
5,707,983 →
Application:
08/806,541 →
Process for Effecting Allylic Oxidation
Patent:
5,869,709 →
Application:
08/851,939 →
Copper-Catalysed Allylic Oxidation Using Alkyl Hydroperoxide
Patent:
6,252,119 →
Application:
08/901,764 →
Memory Enhancement by the Administration of DELTA5-Androstene- 3BETA-Ol-7, 17-Dione and 3 Beta Esters Thereof
Patent:
6,153,606 →
Application:
09/174,235 →
Process for Effecting Allylic Oxidation
Patent:
6,111,118 →
Application:
09/228,902 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Patent:
6,384,251 →
Application:
09/423,467 →
Use of DELTA5-Androstene-3BETA-OL7,17-Dione in the Treatment of Arthritis
Patent:
6,794,374 →
Application:
09/554,951 →
Use of delta 5- androstene -3 beta- ol- 7, 17- dione in the treatment of lupus erythematosus
Patent:
6,372,732 →
Application:
09/554,952 →
Process for Effecting Allylic Oxidation
Patent:
6,686,486 →
Application:
09/639,027 →
Treatment of inflammatory bowel disease by the administration of delta5-androstene-3beta-OL-7,17 dione and metabolizable precursors thereof
Application:
09/665,640 →
Memory by the Administration of DELTA5-Androstene-3BETA-Ol-7,17-Dione and 3BETA Esters
Patent:
6,489,313 →
Application:
09/704,495 →
Method for Diminishing Wrinkles and Fine Lines of the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Patent:
6,399,084 →
Application:
09/799,295 →
Method of Moisturizing the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Patent:
6,399,085 →
Application:
09/799,313 →
Treatment of Dermatitis by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Patent:
6,465,446 →
Application:
09/805,024 →
Use of DELTA5-Androstene-3BETA Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal
Use of DELTA5-Androstene-3BETA-Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application:
10/541,780 →
Publication:
US 2006/0217357
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application:
10/541,781 →
Publication:
US 2006/0135499
Composition and Method for Promoting Weight Loss, Fat Loss or Modulation of Metabolic Rate
Application:
11/570,903 →
Use of Delta 5-Androstene-3 Beta-Ol-7,17-Dione in the Treatment of Arthritis
Application:
60/066,197 →
Use of 5-Androstene-3B-Ol-7,I7-Dione in the Treatment of Lupus Erythematosus
Application:
60/066,198 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Application:
60/078,978 →
Treatment of chronic fatigue syndrome and fibromyalgia synorome by the administration of delta5-androstene-3beta-ol-7,17 dione and metabolizable precursors thereof
Application:
60/250,227 →
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application:
60/439,753 →
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application:
60/439,816 →
Composition containing 7-oxo DHEA, a source of bioavailable chromium, a source of bioavailable calcium, green tea extract and vitamins C & D, and method of promoting weight loss, fat loss or modulation of a dieting-induced change in basal metabolic rate by administration of the composition
Application:
60/599,469 →
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 4, 2009
From: HUMANETICS CORPORATION
To: HOPFENSPIRGER, LARRY
Reel/Frame 023594/0680 →
Assignment of Patent Security Agreement Recorded 04/05/07 with Uspto at Reel 019116, Frame 0641
Jan 27, 2012
From: UNICREDIT BANK AG, NEW YORK BRANCH, AS ATTORNEY-IN-FACT FOR HILCO FINANCIAL, LLC (N/K/A 1310 FINANCIAL, LLC) UNDER POA DATED DECEMBER 24, 2008
To: UNICREDIT BANK AG, NEW YORK BRANCH
Reel/Frame 027612/0709 →
Change of Name
Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
Release of Security Interest
Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033300/0527 →
Assignment of Assignor's Interest
Jul 10, 2014
From: LARDY, HENRY A.; SHI, JENNIFER Y.
To: HUMANETICS CORPORATION
Reel/Frame 033283/0315 →
Release of Security Interest
Jul 10, 2014
From: WHITEBOX ADVISORS, LLC
To: HUMANETICS CORPORATION
Reel/Frame 033289/0553 →
Release of Security Interest
Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033293/0475 →
Assignment of Assignor's Interest
Aug 27, 2014
From: HUMANETICS CORPORATION
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 033645/0212 →
Release and Reassignment of Intellectual Property Security Interests
Aug 23, 2016
From: UNICREDIT BANK AG, NEW YORK BRANCH AS SECURED PARTY IN POSSESSION OF THE ASSETS OF HILCO FINANCIAL LLC
To: HUMANETICS CORPORATION; ADVANTRX CORPORATION
Reel/Frame 039784/0922 →
Release of Security Interest in Patents
Sep 12, 2016
From: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040068/0687 →
Release of Security Interest
Oct 5, 2016
From: MADISON CAPITAL FUNDING LLC
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040234/0538 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, INC.
To: NEURMEDIX, LLC
Reel/Frame 057116/0336 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
Change of Name
Oct 15, 2021
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: LONZA CONSUMER HEALTH INC.
Reel/Frame 057828/0594 →
Change of Name
Oct 26, 2021
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: LONZA CONSUMER HEALTH INC.
Reel/Frame 058299/0672 →